Learn / Conditions / Muscles, joints and limbs
Neuroplastic symptoms · Muscles, joints and limbs

Ehlers-Danlos: flexible joints are inherited, but the pain may be learned.

Many people with hypermobility have no pain at all, which is the clue that something beyond the connective tissue decides how much it hurts.

Karuna LabsUpdated 2026-10-147 min read
The short answer

Ehlers-Danlos syndromes (EDS) are a group of inherited connective tissue disorders affecting mainly the skin, joints and blood vessels, with over-flexible joints that may dislocate, stretchy or fragile skin, and in some rarer subtypes risk to major blood vessels. EDS sits within the wider group of hypermobility spectrum disorders (HSD). Joint pain is often attributed to the hypermobility itself, but the ATNS Index of Neuroplastic Symptoms points out that many people with hypermobility have no pain, so a complete evaluation of pain should include assessment for neuroplastic symptoms, especially when there is no evidence of joint damage or dislocation. Neuroplastic symptoms are real pain produced by a sensitised nervous system rather than by tissue injury, and an approach exists that addresses them.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

What Ehlers-Danlos syndromes are

Ehlers-Danlos syndromes, or EDS, are a group of inherited conditions that affect collagen, the protein that gives skin, joints, ligaments and blood vessel walls their strength and stretch. The most common form, hypermobile EDS (hEDS), causes joints that move beyond the normal range and may subluxate or dislocate, along with soft, stretchy skin that bruises easily. Rarer subtypes, such as vascular EDS, can weaken major blood vessels and need specialist monitoring.

Diagnosis is complex. There are many subtypes, most have no simple blood test, and hEDS itself is one end of a broader group called hypermobility spectrum disorders (HSD). Many people with hypermobile joints are diagnosed only after years of unexplained pain, fatigue, dizziness or gut symptoms. Those symptoms are real. The question this page explores is where they come from.

The neuroplastic contribution

Neuroplastic symptoms are real symptoms, including pain, generated by learned pathways in the brain and nervous system rather than by ongoing damage in the tissues. The nervous system has become a sensitised alarm, turning up the volume on ordinary signals from the body. These symptoms are not imaginary and are not 'all in your head'. Because the brain can change, they are reversible.

The ATNS Index of Neuroplastic Symptoms makes a simple observation: pain in people with flexible joints is often blamed on EDS or HSD, yet many people with hypermobility have no pain at all. If the loose joints alone caused the pain, everyone with loose joints would hurt. So for a complete evaluation, the index says neuroplastic symptoms should be assessed, and that this is particularly important when there is no evidence of joint damage or dislocation. Ways the nervous system becomes involved:

This does not mean the connective tissue is irrelevant. Joint protection, strength work and treatment of true dislocations still matter. It means the pain volume is set by the nervous system, and that volume can be turned down. Our hypermobility spectrum disorder page and joint hypermobility syndrome page cover related ground.

What the research shows

A 2016 study of 27 people with joint hypermobility syndrome or hypermobile EDS used nerve tests and quantitative sensory testing. It found no damage to the sensory nervous system, but did find lowered pain thresholds to heat and cold and an increased 'wind-up' response, where repeated stimuli produce escalating pain. The authors concluded that pain in these conditions likely arises through central sensitization.

An earlier study of people with hypermobile EDS found generalised hyperalgesia: pain sensitivity was raised even in parts of the body that were not symptomatic. The authors suggested this reflects a sensitised central nervous system rather than problems in the painful joints alone. A more recent study of 82 patients with pain and hypermobility, using the Central Sensitization Inventory, found that 86 percent met the questionnaire's threshold for central sensitization.

These are small, single-centre and mostly cross-sectional studies, so they show association, not cause, and a questionnaire cannot diagnose sensitization on its own. Together, though, they point consistently in one direction: pain in hypermobility behaves like sensitised pain. The central sensitization explainer describes what that means.

Signs the brain may be part of the picture

Try this today

Move one joint with safety

Pick a joint that hurts but has not been injured or dislocated. Sit comfortably. Move it slowly through a small, comfortable range, well within what feels safe. As you move, breathe out and say silently: this joint is stable enough for this, and this sensation is my nervous system being protective. Notice the pain with curiosity rather than bracing against it. Repeat five slow movements, pausing between each. Then rest a hand on the joint and notice warmth and weight. Two minutes a day teaches the brain that movement is safe, which is the first step in turning the pain volume down.

A solution that addresses it

There is an approach that addresses the brain's contribution. It is often called pain and symptom reprocessing. It includes education about neuroplastic symptoms, somatic tracking (observing pain with curiosity and safety instead of fear), reducing threat around movement, a graded return to activity, emotional awareness and expression, and acceptance and commitment skills. It is delivered by trained clinicians, works well alongside physiotherapy and joint care, and is increasingly available through digital programs.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If you have EDS or hypermobility and pain that has not responded as expected, you can join the waitlist.

What to do next

Get the structural picture clear. A rheumatologist, geneticist or EDS-aware clinician can confirm the subtype and check for true joint damage, instability or dislocation. If vascular EDS is suspected, that needs specialist monitoring. Seek urgent care for sudden severe chest, abdominal or back pain, a joint that is dislocated and will not reduce, or signs of a bleed.

Once injury has been assessed, ask whether your pain fits a neuroplastic pattern. If it might, start learning and practising. The fear-avoidance page explains why bracing against movement can increase pain, and the fibromyalgia page describes the whole-body sensitised pattern that many people with hEDS recognise.

Questions people ask

Is Ehlers-Danlos syndrome a neuroplastic condition?

No. EDS is an inherited connective tissue disorder. The ATNS Index of Neuroplastic Symptoms says the pain in EDS and hypermobility should be assessed for a neuroplastic contribution, because many hypermobile people have no pain and because research shows sensitised pain processing in those who do.

Why do I hurt when my joints are not damaged?

Pain is produced by the brain based on its assessment of threat, not simply by tissue damage. In hypermobility, fear of dislocation, bracing and years of worry can sensitise the nervous system so that normal signals are felt as pain. Studies in hEDS show lowered pain thresholds even in non-painful areas.

Should I still do physiotherapy and strengthening?

Yes. Stability and strength protect the joints and are a core part of EDS care. Combining them with an approach that reduces fear and sensitisation tends to help the pain more than either alone.

Does this apply to vascular EDS?

Vascular EDS needs specialist monitoring for blood vessel risk, and sudden severe pain must always be checked. Chronic musculoskeletal pain in any EDS subtype can still have a neuroplastic component once dangerous causes are excluded.

References

  1. Central sensitization as the mechanism underlying pain in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type. Di Stefano et al., European Journal of Pain, 2016. PMID 26919608
  2. Chronic pain in patients with the hypermobility type of Ehlers-Danlos syndrome: evidence for generalized hyperalgesia. Rombaut et al., Clinical Rheumatology. PMID 24487572
  3. Evidence for central sensitization as classified by the central sensitization inventory in patients with pain and hypermobility. 2024. PMID 39192465
Source: the definition and neuroplastic-contribution framing on this page summarise, in our own words, the entry “Ehlers Danlos Syndromes” in the Index of Neuroplastic Symptoms (2026) published by the Association for the Treatment of Neuroplastic Symptoms (ATNS, neuroplastic.org). The research summary cites the PubMed records listed above.
Cindra

A daily companion for the hard days and the ordinary ones.

Cindra is an AI companion from Karuna Labs built around acceptance and commitment therapy and the science of neuroplastic symptoms. It checks in with you each day, helps you notice what your symptoms are pulling you away from, and nudges you back toward the things that matter. Cindra is invite-only while we build it with early members.

Join the waitlist

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.